Strategy& Insider

In this episode, Dr. Hadi Saleh, CEO of CeramTec, delves into the intricacies of navigating a shifting MedTech market with the rise of weight-loss blockbuster drugs as well as the influence of macroeconomic and geopolitical tensions on healthcare product development and innovation. The discussion also explores preventive care, the significance of a healthy lifestyle, and the potential of genetic editing and personalized medicine. Tune in for an engaging and informative conversation.

In this episode, we welcome two trailblazers in the field of stem cell research: Join Prof. Dr. Katarina Le Blanc, a leading expert with over two decades of experience, as she shares her groundbreaking work with stem cells and how her research has contributed to the mission of making stem cell treatments and research more accessible through Cellcolabs. Accompanying her is Dr. Mattias Bernow, CEO of Cellcolabs, who brings a unique blend of medical and business expertise to the conversation, revealing strategies to make these revolutionary therapies affordable. Tune in to explore the transformative potential of stem cell research in disease care and prevention.

In this episode, we explore the forefront of rare disease research with Professor Matthew Wood, the Director and Chief Scientific Officer at the Oxford-Harrington Rare Disease Centre (OHC). Professor Wood shares his inspiring journey from his early studies in Cape Town to his impactful career at Oxford University. Learn about the innovative initiatives at OHC and their ambitious plan to bring 40 drugs into clinical trials within the next decade. This episode provides valuable insights into the challenges and opportunities in rare disease treatment, presenting a hopeful vision for rapid diagnosis and effective therapies.

Prof. Dr. Mandy Mangler stands out as a prominent voice for change in women's healthcare. As the Medical Director and Chief Physician at two leading Berlin clinics, she champions the empowerment of women by stressing the critical need for evidence-based knowledge about their bodies, health, and sexuality. This episode covers a wide array of topics, including childbirth, menstruation, sexual education, common gynecological disorders, as well as menopause and aging. It highlights the urgent need to address persistent misconceptions and inequalities, advocating for a more patient-centric healthcare system.

Join Dr. Cornelius Maas, a former professional handball player who is now a partner at SHS Capital, a private investment firm specializing in medical technology and life sciences in the GSA region. Explore the unique challenges and groundbreaking trends poised to transform the industry and learn about the crucial systemic changes needed in Germany's healthcare system to ignite innovation and retain talent. Tune in for a compelling discussion on the future of healthcare and the pivotal role of private equity in driving progress.

In this Strategy& Insider podcast episode with Ambra Zhang, Co-founder and CEO of Juniper, we explore the groundbreaking approach her UK-based startup is taking in the realm of reproductive health insurance. Discover how Juniper is addressing significant health challenges, like endometriosis and prostate cancer, by destigmatizing discussions and implementing innovative insurance solutions.

In this episode, Clemens Utschig-Utschig, CTO at Boehringer Ingelheim, guides us through the digital and technological transformation of a 140-year-old family-owned pharmaceutical company. Explore how he utilizes data and technology to revolutionize drug development and personalized medicine, first and foremost quantum computing. Gain insights into strategic partnerships with BigTech and delve into a number of further leapfrog technologies in healthcare.

Christian Angermayer, serial entrepreneur and founder of Apeiron Investment Group, is passionate about longevity and mental health, with the aim to make human life longer, better, and happier. Listen to an insightful episode about conquering aging, enhancing quality of life, and how psychedelics could revolutionize mental health treatment.

As an Associate Professor at Yale School of Medicine, a practicing anesthesiologist and the Medical Director of Sustainability for the Yale New Haven Health System, Dr. Jodi Sherman is an internationally recognized clinician and academic in the emerging field of sustainability in healthcare. Tune in to an eye-opening conversation about healthcare pollution, ecologically sustainable practices in healthcare and the impact of health professionals for driving the sustainable transformation.

Daniel Eriksson, the founder and CEO of the Nordic Center for Sustainable Healthcare (NCSH), is at the forefront of fostering collaboration, projects, business, knowledge, and innovation among diverse stakeholders to make the healthcare industry more sustainable. The NCSH's prestige project is “Grønnköpingkið” – the world's greenest hospital, a digital platform showcasing best practices and technologies to increase the sustainability performance of healthcare facilities. Don't miss this truly insightful conversation as we explore the power of sustainability in transforming the healthcare industry.

In this special episode, our host Thomas welcomes two familiar faces: Prof. Dr. Andreas Wicki from the Zurich University Hospital and Prof. Dr. Bernd Bodenmiller from the University of Zurich and ETH Zurich – both former podcast guests in solo episodes – share their vision to transform cancer diagnosis, treatment, and management through cutting-edge tumor profiling techniques and exploratory research. Tune in and find out about recent developments in cancer research, the power of data and technology – and how AI can revolutionize precision oncology.

In this episode, Bijoy Sagar, Executive Vice President, Chief Information Technology and Digital Transformation Officer at Bayer, discusses the transformative power of digital technology for the pharmaceutical landscape. In his view, groundbreaking digital advancement brings us to the cusp of another revolution in healthcare, reshaping our perception of pharmaceuticals. Furthermore, Bijoy explores how quantum computing addresses the limitations of AI and discusses the promising future of cell and gene therapy as the next transformative step in human medicine's evolution.

Sarah Lidé is the Deputy CEO of Medicon Village Innovation, which is the largest science park in Scandinavia focused on life science, based in Lund. Working at the intersection of academia, corporate players and healthcare providers, she is an expert in aligning stakeholders from biotech, pharma, research, healthcare providers and start-ups to facilitate world-class research innovation and thereby giving people a healthier and better life. Tune in to a truly insightful conversation about partnership, collaboration and research innovation.

The ultimate vision of precision healthcare is to allow each individual patient access to personalized medicines. By developing 2D and 3D printers as well as the software and the active pharmaceutical ingredients, Prof. Dr. Christian Franken – co-founder and managing shareholder of DiHeSys Digital Health Systems GmbH – and his team pursue the vision to allow every patient access to personalized medicines and making drug therapy less complex. Tune in to our latest episode and dive into the added values and the challenges that come with it, and how to foster a positive attitude towards the huge potential of digitization in healthcare.

It is a well-known fact that the potential of data in healthcare is huge. While some see data protection as a barrier, Elena Bonfiglioli – General Manager of Microsoft Healthcare – advocates that data privacy is in fact a key enabler for cutting-edge innovation and that privacy-enhancing solutions are crucial to reap the full power of the cloud. Tune in to our latest episode to learn how data can make pharma and healthcare more efficient and how AI can help extend our capabilities.

In this episode, it instantly becomes clear why it is a privilege to help humankind by reaping cutting-edge science and technology for Dr. Christian Rommel. As the Head of R&D and member of the executive board at Bayer Pharmaceuticals, he shares his experience in transforming how we are developing and regulating drugs, his view on the key to future medical innovation, and addresses how to enable patients to benefit from such innovations.

In this episode, Emil Hewage, CEO and co-founder of BIOS Health – a pioneering and awarded neural engineering startup from Cambridge – shares his visionary ideas for the future of healthcare, innovative treatments, and personalized medicine. His innovations are true game changers as he uses his expertise to spearhead the use of artificial intelligence for interpreting neural data, and by doing so, created new fields of precision medicine.

James Zackheim, Head of Corporate Strategy at global biopharmaceutical company UCB, shares what he foresees as the greatest benefits through collaborations between the pharma industry with tech companies. As these new partnerships, with the help of big data and AI, could accelerate the shift towards more preventive medicine and streamline the use of readily available data, however, there is also a disruptive threat from the new tech players that pharma should prepare for.

Cancer is still one of the most common diseases worldwide, and one of the top causes of death – also because there is no known cure yet. As this makes prevention all the more crucial for patients, we spoke to renowned researcher for biomedicine and scientific author Bernd Bodenmiller about his strong passion and commitment towards better understanding cancer.

The fourteenth episode features Betül Susamis Unaran, who is the Chief Strategy and Digital Officer at Zur Rose Group. She talks about the firm's ambition to create a new healthcare ecosystem that connects healthcare products, digital healthcare services and third-party service offerings.

We are honored to welcome Aashima Gupta, Director of Global Healthcare Strategy and Solutions at Google Cloud, as the latest guest to our podcast. She shares how artificial intelligence can augment human productivity in patient care, why the future healthcare model is going to be hybrid, why data interoperability is key for empathetic patient experiences, and where the holy grail for a holistic understanding of a patient’s interaction with healthcare lies.

This episode features Dr. Sachin Jain who is the CEO of Scan Health Plan and who used to serve in the Obama administration. This conversation is about the benefits of virtual specialty care, why we should strive for a better normal instead of a new normal and what it takes to achieve real transformation within the healthcare sector.

For the first time, we welcome two guests to our podcast: Henrik Matthies and Julia Hagen from the Health Innovation Hub (hih) share their insights straight out of the ,digital forge' of Germany's Federal Ministry of Health. They stress the importance of an ecosystem approach and explain how COVID-19 may have a silver lining for the digitization of healthcare.

The tenth episode revolves around the digitization of mental healthcare. Our guest Nora Blum – founder and CEO of the German start-up Selfapy – illustrates that digital apps are a decisive tool in the treatment of mental diseases and increasingly help patients with depressions, eating disorders and other psychiatric illnesses to receive faster and more flexible medical care.

The ninth episode brings you ever closer to the future of healthcare with Thomas discussing the possibilities of digital biomarkers for modern medicine with Dan Vahdat, founder and CEO of Huma (formerly: Medopad). Together, they shed light on the prospect of diagnosing diseases in the earliest stages and how this contributes to a more preventative and personalized care for patients.

While COVID-19 makes it necessary for the healthcare system to increase use of digital means at the moment, this could also function as a digitization catalyst and create sustainable change. Dr. Johannes Wimmer, Germany's leading TV doctor, explains why this would be a positive outcome of the crisis in the podcast's eighth episode.

Together with Prof. Dr. Christiane Woopen, medical ethicist and Executive Director of ceres at the University of Cologne, Thomas discusses the implications of COVID-19 for basic human rights and that health is only one of our fundamental goods, whereas freedom is the highest good from an ethical perspective.

Peter Albiez, Chairman of the Management Board of Pfizer Germany, is our latest podcast guest with whom Thomas talked about his vision for healthcare to reward health rather than sickness. Listen now to learn what other opportunities health and life sciences offer to future competitiveness and progress.

The fifth episode brought Thomas to the United Arab Emirates where he met with Dr. Hamed Al Hashemi, Director for Strategy, Performance and Risk at the Department of Health in Abu Dhabi. Find out how the emirate plans to integrate new means of technology into its healthcare system by capitalizing the knowledge available and co-creating a vision for the future of health with all relevant stakeholders.

In the fourth episode Thomas and Dr. Georg Matheis, cardiac surgeon and one of Germany’s pioneering founders in healthcare, discuss how to regain the patient-physician relationship, megatrends in surgery, and the current situation of healthcare in Europe.

In the third episode, Teresa Graham, Head of Global Product Strategy at Roche Pharma, discusses the role big tech companies will play and how technology will change how patients access medicine in the future.

In the first episode, Thomas meets with Chief Oncologist at Universitätsspital Baselland, Dr. Andreas Wicki. Tune in to learn about how data analytics will help medicine move from curing diseases to preventing them and who will win the race around steering the future of health.

In the second episode of the Future of Health podcast series, Thomas discusses the changes data-driven biomedicine will bring to the healthcare sector with Prof. Dr. Torsten Schwede, Vice President for Research and professor for bioinformatics at University of Basel.

Welcome to the Strategy& Insider Podcast. In our first season, we will discuss some of the most fundamental questions about the Future of Health. Our guests are experts across all sectors of the healthcare industry including pharma executives, leading academics and medical physicians.